Sustainable Insight Capital Management LLC Has $6.18 Million Holdings in Humana Inc. (NYSE:HUM)

Sustainable Insight Capital Management LLC decreased its stake in shares of Humana Inc. (NYSE:HUM) by 38.9% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 24,342 shares of the insurance provider’s stock after selling 15,488 shares during the period. Humana accounts for about 2.7% of Sustainable Insight Capital Management LLC’s holdings, making the stock its 13th largest position. Sustainable Insight Capital Management LLC’s holdings in Humana were worth $6,176,000 as of its most recent filing with the SEC.

A number of other institutional investors have also made changes to their positions in HUM. EverSource Wealth Advisors LLC increased its stake in shares of Humana by 25.8% in the second quarter. EverSource Wealth Advisors LLC now owns 375 shares of the insurance provider’s stock worth $136,000 after purchasing an additional 77 shares during the period. Public Sector Pension Investment Board increased its position in Humana by 71.5% in the 2nd quarter. Public Sector Pension Investment Board now owns 4,622 shares of the insurance provider’s stock worth $1,727,000 after buying an additional 1,927 shares during the period. Evergreen Capital Management LLC acquired a new position in shares of Humana during the second quarter worth approximately $328,000. Bank of Montreal Can lifted its holdings in shares of Humana by 6.9% during the second quarter. Bank of Montreal Can now owns 159,708 shares of the insurance provider’s stock worth $59,699,000 after buying an additional 10,326 shares during the last quarter. Finally, BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp boosted its position in shares of Humana by 56.6% in the second quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp now owns 23,090 shares of the insurance provider’s stock valued at $8,628,000 after acquiring an additional 8,346 shares during the period. 92.38% of the stock is owned by institutional investors.

Humana Price Performance

Humana stock opened at $293.22 on Friday. The stock has a market cap of $35.31 billion, a price-to-earnings ratio of 25.97, a P/E/G ratio of 2.15 and a beta of 0.55. Humana Inc. has a 12-month low of $213.31 and a 12-month high of $411.80. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.67. The business’s 50-day simple moving average is $273.81 and its 200 day simple moving average is $305.88.

Humana (NYSE:HUM) last announced its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share for the quarter, beating the consensus estimate of $3.48 by $0.68. Humana had a net margin of 1.18% and a return on equity of 13.20%. The business had revenue of $29.30 billion for the quarter, compared to analyst estimates of $28.66 billion. As a group, research analysts anticipate that Humana Inc. will post 16.11 earnings per share for the current year.

Wall Street Analyst Weigh In

Several equities analysts recently commented on the stock. KeyCorp started coverage on shares of Humana in a research note on Friday, October 11th. They set a “sector weight” rating for the company. Deutsche Bank Aktiengesellschaft reduced their target price on shares of Humana from $349.00 to $250.00 and set a “hold” rating for the company in a research note on Thursday, October 3rd. UBS Group lowered their price target on Humana from $380.00 to $250.00 and set a “neutral” rating on the stock in a research note on Friday, October 4th. Leerink Partnrs downgraded Humana from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, October 2nd. Finally, Stephens restated an “equal weight” rating and set a $250.00 price objective on shares of Humana in a research report on Wednesday, October 9th. Twenty research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $302.80.

Insider Buying and Selling at Humana

In related news, insider Timothy S. Huval sold 3,703 shares of the stock in a transaction that occurred on Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total value of $948,930.78. Following the sale, the insider now directly owns 8,181 shares in the company, valued at $2,096,463.06. This trade represents a 31.16 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Insiders own 0.32% of the company’s stock.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.